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Cytotoxicity of crystals involves RIPK3-MLKL-
mediated necroptosis
Shrikant R. Mulay1, Jyaysi Desai1, Santhosh V. Kumar1, Jonathan N. Eberhard1, Dana Thomasova1,
Simone Romoli1, Melissa Grigorescu1, Onkar P. Kulkarni1, Bastian Popper2, Volker Vielhauer1,
Gabriele Zuchtriegel3,4, Christoph Reichel3,4, Jan Hinrich Bra¨sen5, Paola Romagnani6, Rostyslav Bilyy7,
Luis E. Munoz8, Martin Herrmann8, Helen Liapis9,10, Stefan Krautwald11, Andreas Linkermann11
& Hans-Joachim Anders1
Crystals cause injury in numerous disorders, and induce inﬂammation via the NLRP3
inﬂammasome, however, it remains unclear how crystals induce cell death. Here we report
that crystals of calcium oxalate, monosodium urate, calcium pyrophosphate dihydrate and
cystine trigger caspase-independent cell death in ﬁve different cell types, which is blocked by
necrostatin-1. RNA interference for receptor-interacting protein kinase 3 (RIPK3) or mixed
lineage kinase domain like (MLKL), two core proteins of the necroptosis pathway, blocks
crystal cytotoxicity. Consistent with this, deﬁciency of RIPK3 or MLKL prevents oxalate
crystal-induced acute kidney injury. The related tissue inﬂammation drives TNF-a-related
necroptosis. Also in human oxalate crystal-related acute kidney injury, dying tubular cells
stain positive for phosphorylated MLKL. Furthermore, necrostatin-1 and necrosulfonamide, an
inhibitor for human MLKL suppress crystal-induced cell death in human renal progenitor cells.
Together, TNF-a/TNFR1, RIPK1, RIPK3 and MLKL are molecular targets to limit crystal-
induced cytotoxicity, tissue injury and organ failure.
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C
rystals are deposits of various sizes and shapes composed
of atoms, ions or biomolecules, frequently with tissue
injury, inﬂammation and remodelling. Two mechanisms
may explain this association: (I) nucleation or crystal growth
from a seed crystal formed on a surface medium, for example
tubular epithelial cells, urolithiasis forming at Randall’s plaques,
calciﬁcations in injured tendons, damaged cartilage or ather-
omatous vascular lesions, (II) crystal formation itself causes tissue
injury and inﬂammation, for example in gouty arthritis,
pulmonary silicosis or asbestosis, cholesterol crystals driving
atherogenesis and in oxalate, cystine or urate nephropathy.
Crystals trigger tissue inﬂammation via the NLRP3 inﬂamma-
some- and caspase-1-mediated secretion of IL-1b and IL-18
(refs 1–5). However, crystals also exert direct cytotoxic effects
leading to necrotic rather than apoptotic cell death6,7. It is still
unknown, whether crystal deposition causes necrosis in a passive-
mechanical or in one of the recently identiﬁed modalities of
regulated cell death8–18. We hypothesized that crystal-induced
tissue injury involves a regulated form of cell death and that the
identiﬁcation of this pathway may reveal new targets for
therapeutic intervention that limit crystal-related tissue injury
and organ dysfunction. Our results show that various crystals
uniformly induce necroptosis, that is, a receptor-interacting
serine-threonine kinase 3- (RIPK3) and mixed lineage kinase
domain-like (MLKL)-dependent form of primary necrosis
in vitro, in vivo and in human disease. These data identify
several molecular targets for pharmacological intervention to
limit tissue injury in crystallopathies.
Results
Various crystals cause primary cellular necrosis. What is the
mode of crystal-induced cell death? To address this question we
ﬁrst studied the cytoxic effects of calcium oxalate (CaOx),
monosodium urate (MSU), calcium pyrophosphate dihydrate
(CPPD) and cystine crystals on kidney epithelial cells in vitro.
Transmission electron microscopy images and rhodamine-sytox
stains to identify living and dead cells, respectively, showed that
kidney tubular epithelial cells die by primary necrosis after crystal
exposure (Fig. 1a). In addition, we employed ﬂow cytometry to
better characterize the mode of CaOx-induced cell death.
To this end sideward scatter, forward scatter, Hoechst 33342,
annexin V, 1,10-dioctadecyl-3,3,30,30-tetramethyl-indocarbocya-
nine perchlorate, and prodidium iodide were measured. We
found that CaOx crystals induced primary necrosis without signs
of apoptosis (Fig. 1b,c), evidenced by pan-caspase inhibition not
affecting cytotoxicity of any of the aforementioned crystals
(Fig. 1d). Also the kinetics of crystal cytotoxicity were caspase
independent (Supplementary Fig. 1A) and absence of NLRP3 did
not affect CaOx crystal-induced cytotoxicity (Supplementary
Fig. 1B). This, being a caspase-independent mode of cell death,
excluded NLRP3-caspase-1/11-dependent pyroptosis10,11. We
conclude that crystal cytotoxicity does not involve apoptosis or
pyroptosis but largely represents primary cellular necrosis.
Cytotoxicity of crystals involves the necroptosis pathway.
Having excluded the contribution of caspase-dependent forms of
cell death, we focussed on necroptosis, a known regulated form of
necrosis of non-immune cells13. We found the key proteins of the
necroptosis pathway, that is, tumour-necrosis factor receptor-1
(TNFR1), RIPK1, RIPK3 and MLKL to be induced in tubular
epithelial cells on exposure to various crystals (Fig. 2a). The
RIPK1 stabilizer necrostatin-1 (ref. 19) partially (MSU, CPPD
and cystine) or entirely (CaOx) prevented crystal-induced tubular
epithelial cell death also in the absence of ZVAD–FMK
(Fig. 2b and Supplementary Fig. 1C), suggesting a role for
RIPK1 independent of caspases. When crystals were replaced by
recombinant TNF-a as a stimulus, necrostatin-1 had the same
effect. However, TNFR1 was not required for crystal-induced cell
death in vitro (Supplementary Fig. 1B). Necrostatin-1 also
suppressed crystal cytotoxicity in L929 cells, primary human
synovial ﬁbroblasts and HK-2 cells (Supplementary Fig. 2). The
protective effect of necrostatin-1 on the cytotoxicity of crystals
was conﬁrmed by ﬂuorescence imaging using the cell death
marker prodidium iodide that enters cells only on the disruption
of the plasma membrane (Fig. 2c). Both Ripk3 or Mlkl deﬁciency
or knockdown of either RIPK3 or MLKL with speciﬁc siRNA
partially abrogated, whereas knockdown of caspase-8 somewhat
enhanced crystal-induced cytotoxicity in tubular epithelial cells
(Fig. 3a–c and Supplementary Fig. 3). Furthermore, pre-treatment
with the putative inhibitor of RIPK3 dabrafenib also protected
tubular epithelial cells from crystal-induced cytotoxicity in a
dose-dependent manner (Fig. 3d). Together, these data imply that
crystal-induced primary necrosis may involve RIPK3/MLKL-
dependent necroptosis.
Ripk3 and Mlkl deﬁciency blocks crystalline necrosis in vivo.
Crystal nephropathy (CN) is an example of crystal-induced tissue
injury and organ failure20,21. Mice exposure to oxalate induces
oxalate nephropathy, a model that mimics CN in humans,
including an increase of serum creatinine and blood urea nitrogen
(BUN)5,20,22. Acute oxalate exposure leads to CaOx crystal
deposition in the mouse kidney. At the structural level CaOx
crystal plugs forms within the proximal and distal tubules
(Fig. 4a–d). CaOx crystals are also found within the interstitium
(Fig. 4c). Transmission electron microscopy detected luminal
crystal plugs and smaller sized crystals within tubular epithelial
cells (Fig. 4e–g). Injured epithelial cells often exhibited
ultrastructural signs of necrosis, such as loss of electon density
and balloning of the mitochondria, nuclear chromatin
irregularities, outer membrane disruption, and cytoplasm and
organelle expulsion (Fig. 4h). Quick-freeze deep-etch electron
microscopy illustrates crystal deposition involving cytoplasmic
organelles on rupture of plasma membranes (Fig. 4i). Thus,
crystal formation within the kidney is associated with necrosis of
tubular epithelial cells in a temporal and spatial manner. The
phenotype is associated with the induction of renal expression of
TNFR1, RIPK1, RIPK3 and MLKL messenger RNA (mRNA)
(Fig. 5a). We validated the in vivo contribution of this pathway by
inducing oxalate nephropathy in wild type and Ripk3- and
Mlkl-deﬁcient mice. Oxalate exposure induced identical CaOx
crystal deposits in both mouse strains (Fig. 5b), but all functional
and structural parameters of acute CN were signiﬁcantly reduced
in Ripk3- or Mlkl-deﬁcient mice (Fig. 5c–h). These include serum
creatinine levels, markers of tubule necrosis and neutrophil
recruitment. These results show that the necroptosis-related
proteins RIPK3 and MLKL mediate oxalate crystal-induced cell
necrosis in vivo.
RIPK1 does not mediate neutrophil recruitments. We perfor-
med several in vitro and in vivo experiments to test the possibility
that tubule protection in Ripk3- and Mlkl-deﬁcient mice is a
secondary effect possibly due to a role of RIPK1–RIPK3–MLKL
signalling in neutrophil recruitment. Intraperitoneal (i.p.) injection
of various types of crystals induced neutrophil recruitment into the
peritoneal cavity as a marker of crystal-induced peritonitis, which
was not affected by necrostatin-1 (Fig. 6a,b). Injection of crystals
into air pouches at the back of mice with and without systemic
necrostatin-1 treatment gave identical results (Fig. 6c and
Supplementary Fig. 4). Importantly, we assured the plasma activity
of the same charge of necrostatin-1 in vivo in a similar time frame
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Figure 1 | Crystals induce primary cell necrosis. (a): Various crystals were incubated with tubular epithelial cells as indicated. Images show the crystal
shapes at a magniﬁcation of  1,000 (left), TEM images shows that these crystals induce necrosis of tubular epithelial cells as indicated by ruptured
plasma membranes (middle,  2,000), scale bar, 2 mm. The images on the right show the same rhodamine-labelled monolayers (red) 24 h later. When
Sytox green is added to the medium cells with permeable plasma membranes turn green indicating cell death ( 200), scale bar, 40 mm. (b) Flow
cytometry was used to deﬁne the type and stage of tubular cell (MTC) death on CaOx crystal exposure or ultraviolet light type B for 90 s (s) over a
period of 50 h as described in methods. Data for viable cells, apoptotic cells and necrotic cells are expressed as the percentage of viable cells±s.e.m. of all
cells for each time point. (c): The graphs show a quantitative analysis of the same experiment displaying all different phenotypes of tubular epithelial
cells. Flow cytometry cell death deﬁnitions are described in the methods section. (d) Mouse tubular epithelial cell viability on crystal exposure by 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay with and without the pan-caspase inhibitor ZVAD–FMK–FMK. All data are mean±s.e.m. of at
least three independent experiments. CaOx, MSU, CPPD, NS, not signiﬁcant. *Po0.05 versus medium control, ***Po0.001 versus respective control. TEM,
transmission electron microscopy.
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by testing microvascular permeability and leucocyte extravasation
during postischemic cremaster muscle injury (Fig. 6d–f). We
conclude that the necrostatin-1-mediated effects on tissue injury do
not involve a direct effect on neutrophil recruitment.
TNFR1 triggers tubular cell necroptosis in vivo. Crystals did
not require TNFR1 to induce tubular epithelial cell necroptosis
in vitro, necrosis-driven renal inﬂammation (‘necroinﬂamma-
tion’) may induce additional TNF-a-triggered necroptosis in vivo,
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Figure 2 | Crystal cytotoxicity involves the necroptosis pathway. (a): Protein expression of TNFR1, RIPK1 and RIPK3 was determined by western blot from
total proteins isolated 18 h after stimulation of mouse tubular epithelial cells with crystals of CaOx (1,000 mgml 1), MSU (500mgml 1), CPPD
(500mgml 1) and cystine (500mgml 1). b-actin was used as loading control. (b) Mouse tubular epithelial cells were exposed to different concentrations
of CaOx, MSU, CPPD or cystine crystals as indicated in the presence or absence of necrostatin (Nec)-1 (100mM) together with the pan-caspase inhibitor
ZVAD–FMK–FMK (10mM). Cell viability was assessed by MTT assay 24 h later. Data are expressed as mean cell viability±s.e.m. of three independent
experiments. Baseline viability is set as 100%. (c) In similar experiments necrotic tubular epithelial cells were identiﬁed via propidium iodide positivity and
the results were expressed as mean ﬂuorescent intensity on digital analysis of pictures taken from culture dishes. Representative images are shown at an
original magniﬁcation of  200, scale bar ,40mm. Data were analysed using Student’s t-test. *Po0.05, **Po0.01 and ***Po0.001 versus respective
medium control. NS, not signiﬁcant. MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.
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for example, via surface TNFR1 on tubular epithelial cells. Renal
mRNA and protein levels of TNF-a and TNFR1 were induced in
CaOx nephropathy at 24 h (Supplementary Fig. 5A–C). A careful
analysis of early time points of oxalate nephropathy revealed that
kidney injury occurred several hours before intrarenal TNF
expression (Supplementary Fig. 6). Flow cytometry revealed that
TNF-a was not only expressed by intrarenal mononuclear pha-
gocytes but also by non-immune cells (Supplementary Fig. 5D).
Immunostaining localized TNF-a expression to tubules but also
interstitial cells, while TNFR1 and -2 were mostly induced in
tubular epithelial cells (Supplementary Fig. 5E). To test for a
possible functional contribution of TNFR signalling we induced
CN in Tnfr1-deﬁcient and Tnfr1/2 double-deﬁcient mice. Oxalate
exposure resulted in identical CaOx crystal deposits in all mouse
strains, however, all functional and structural parameters of acute
CN were signiﬁcantly reduced in Tnfr1-deﬁcient mice (Fig. 7).
These include serum creatinine levels, BUN, tubule necrosis
and neutrophil recruitment. Concomitant deﬁciency in TNFR2
had no additive effects on this phenotype, suggesting that
TNFR1 mainly accounts for this effect. Thus, although direct
crystal-induced necroptosis does not require TNFR1, in vivo,
crystal-induced necroinﬂammation involves additional TNFR1
signalling-related cell death23, which contributes to CN.
Novel therapeutic targets to abrogate crystal nephropathy in vivo.
If TNFR1/RIPK1/RIPK3/MLKL-mediated necroptosis drives
tubule necrosis in CN then inhibition of either TNF-a, TNFR
signalling or RIPK1 might be valuable therapeutic targets.
To test this hypothesis we treated mice with the TNF-a blocker
etanercept, the TNFR internalization inhibitor R-7050, or with
necrostatin-1. Oxalate exposure resulted in equal amounts of CaOx
crystal deposits in all groups of mice but etanercept, R-7050 or
necrostatin-1 signiﬁcantly reduced all functional and structural
aspects of CN, that is, serum creatinine levels, tubule necrosis,
neutrophil inﬂux and the mRNA expression of kidney injury
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Figure 3 | Suppression of RIPK3 and MLKL prevents crystal cytotoxicity. (a–c) Mouse tubular epithelial cells were transfected with speciﬁc small
inhibitor (si) RNA for RIPK3 and MLKL or a control siRNA of scrambled sequence before being exposed to crystals of CaOx (1,000 mgml 1), MSU
(500mgml 1), CPPD (500mgml 1) and cystine (500mgml 1). Cell viability was assessed by MTTassay (a) and cell death was assessed quantifying PI
positivity (b) and C shows representative images 24 h later. Original image magniﬁcation:  200, scale bar, 100mm. (d) Mouse tubular epithelial cells were
pretreated with RIPK3 inhibitor dabrafenib before exposing to different type crystals. Cell viability was assessed by MTT assay 24 h later. Data are
expressed as mean±s.e.m. of three independent experiments, and was analysed using Student’s t-test. Baseline viability is set as 100%. *Po0.05,
**Po0.01 and ***Po0.001 either versus control siRNA. MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; PI, prodidium iodide.
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markers (Fig. 8). Thus, crystal-induced TNF-a release and the
subsequent TNFR1-triggered activation of RIPK1–RIPK3–MLKL-
executed tubular cell necroptosis represent therapeutic targets in
CN. Using etanercept, R-7050 or necrostatin-1 may have ther-
apeutic potential.
Phosphorylated MLKL in human acute oxalate nephropathy.
To test validate our mouse data in human disease we ﬁrst analysed
crystal cytotoxicity in human renal progenitor cells, that are
considered to contribute to the turnover of tubular epithelial cells
and their regeneration upon injury24. For all the crystals tested the
results were identical to the other cell types examined before
(Fig. 9a–d and Supplementary Fig. 7). Of 64,000 renal biopsies,
1,119 cases (1.7%) with documented CaOx crystals were identiﬁed
by light microscopy and birefringence under polarized light. In all,
412 of these 1,119 cases (37 or 0.6% of total) biopsy cases showed
CaOx crystals in association with acute tubular injury, which
represented 10% of all 4,125 biopsy cases with acute kidney injury
as the leading clinical diagnosis. Immunostaining revealed diffuse
tubular positivity for TNF-a, TNFR1 and total MLKL, while
phosphorylated MLKL was detected only in single cells (Fig. 9e).
We conclude that crystal-induced cytotoxicities of human and
murine kidney cells are comparable and that human tubular
epithelial cells also activate MLKL in the context of oxalate crystal-
induced acute kidney injury.
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Figure 4 | Acute oxalate nephropathy involves tubular epithelial cell necrosis. Oxalate exposure leads to diffuse intrarenal crystal formation as displayed
by Pizzolato stain (a), scale bar, 1mm. In contrast to healthy control mice (b) CaOx crystals form large stone-like plugs that obstruct the tubular lumen
focally (c) smaller crystals attach to the luminal surface and also appear within the tubular cell cytoplasm. Scale bar, 20 mm (d) Scanning electron
microscopy view of the lumen of CaOx exposed tubules conﬁrms disruption of the proximal tubular brush boarder. Scale bar, 10mm. Transmission electron
microscopy shows intact proximal (e) and distal tubules (f) of control mice and luminal crystal plugs and intracellular crystals in mice exposed to CaOx
(g). Scale bar, 5mm. In many tubules crystal deposition is spatially associated with tubular epithelial cell necrosis, characterized by organelle swelling,
cytoplasmic oedema and rupture of the plasma membrane with nuclear expulsion ((h) and all four panels of (i)). Scale bar, 2 mm. (j) Freeze fracture
electron microscopy shows sheets of CaOx crystals (arrow head) in the cytoplasm (*) of tubular epithelial cells. Scale bar, 100 nm.
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Discussion
Various crystals trigger cell death and inﬂammation. While
inﬂammation was traditionally thought to be secondary to tissue
injury, the discovery of crystals being agonists of the NLRP3
inﬂammasome raises the question whether crystal cytotoxicity
is a consequence of NLRP3 activation or an inﬂammasome-
independent event with distinct signalling pathways1. Crystals
are NLRP3 agonists, which could imply triggering also
NLRP3-caspase-1/11-mediated pyroptosis, a mode of regulated
cell death occurring in infected macrophages10–12. We excluded
this option as Nlrp3-deﬁciency or caspase blockade did not affect
crystal cytotoxicity. Caspase blockade virtually also excluded
apoptosis as another form of regulated cell death, which was
consistent with our ﬂow cytometry results and the results of a
previously published report6. In contrast, we found that the
cytotoxicity of crystals involves necroptosis, an injury-driven
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from ﬁve mice in each group. Data were analysed using one-way ANOVA with post hoc Bonferroni’s correction. *Po0.05, ***Po0.001 versus wild-type
mice. ANOVA, analysis of variance; PAS, periodic acid-Schiff; RT–PCR, reverse transcription PCR.
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form of regulated cell death driven by the phosphorylation of the
pseudokinase MLKL13,14,25–27. Knockdown of RIPK3 and MLKL
almost entirely abrogated crystal cytotoxicity in vitro, suggesting
strongly that necroptosis is the predominant form of crystal-
induced cell death13,14,28. As further lines of evidence, lack of
Ripk3 and Mlkl also almost entirely abrogated oxalate
nephropathy in vivo. These data further support the concept
that cell necrosis is the initial event of crystal-induced
necroinﬂammation and that blocking necroptosis during the
early stage of tissue injury is sufﬁcient to prevent subsequent
auto-ampliﬁcation loop of inﬂammation, immune-mediated
pathology and organ failure29. However, RIPK3 is also involved
in NLRP3 inﬂammasome activation30, which is an important
trigger of tissue inﬂammation in oxalate nephropathy5. Of note
NLRP3 and ASC deﬁciency both lacked oxalate-induced kidney
injury, and was exclusively mediated by intrarenal dendritic cells,
which excludes any inﬂammasome signalling in non-immune
kidney cells. Therefore, the in vivo phenotype of the RIPK3
knockout may also involve impaired NLRP3/ASC signalling in
intrarenal dendritic cells.
Providing evidence that necroptosis is also involved in human
disease is difﬁcult because the different forms of regulated
necrosis cannot be distinguished by ultrastructural morphological
criteria. To resolve this issue we used immunostaining for
phosphorylated MLKL, which suggests MLKL-dependent
regulated necrosis also in human oxalate nephropathy.
Necrostatin-1 keeps RIPK1 in an anti-necroptotic conforma-
tion and protected from crystal-induced cytotoxicity. As RIPK1
interacts with the intracellular domain of TNFR1 via its death
domain31 and TNFR1-mediated necroptosis is considered a
prototype of regulated necrosis8, it is tempting to speculate that
RIPK1 loses its protective function against crystal-induced organ
failure presumably by post-translational events, such as
deubiquitination on TNFR1 ligation. Consistently, lack of
TNFR1 or treatment with etanercept abrogated CN in vivo, but
not crystal-induced cytotoxicity in vitro. This should relate to the
lack of direct interaction between crystals and TNFR1 and the
absence of TNF-a in the in vitro system (Supplementary Fig. 8).
In vivo, however, TNF-a is secreted by inﬁltrating immune
cells, which triggers necroptosis in additional cell populations
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secondary to the initial direct activation by crystals, thus
contributing to the auto-ampliﬁcation loop of necroinﬂamma-
tion29. The selective expression of TNF-a and TNFR1 in tubules
of human oxalate nephropathy implies a similar role also in
human disease.
How exactly crystals trigger RIPK1 activation remains
uncertain. MSU crystals can induce Syk signalling in dendritic
cells via biding to lipid rafts32. MSU crystals also affect signalling
by binding to the surface receptor Clec12A but this interaction
does not apply to other crystals33. Crystals activate the NLRP3
inﬂammasome via lysosomal leakage of cathepsins into the
cytosol34. Cathepsin B was reported to inhibit necroptosis
by cleaving RIPK1 (ref. 35). This could also be an avenue of
crystal-induced necroptosis.
In conclusion, crystal cytotoxicity involves necroptosis as a
form of regulated cell death in vitro and in vivo. In vivo,
also secondary TNF-driven necroptosis adds in (Fig. 10).
Consequently, the therapeutic blockade of this pathway, for
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example, with soluble TNFR2-IgG fusion protein or the RIPK1
stabilizer necrostatin-1, can prevent crystal-induced tissue
necrosis and organ dysfunction. These ﬁndings imply TNFR1,
RIPK1, RIPK3 and MLKL being potential therapeutic targets to
limit tissue injury in crystallopathies.
Methods
Animal studies. C57BL/6N mice were procured from Charles River Laboratories
(Sulzfeld, Germany). Tnfr1 / and Tnfr2 / mice were originally obtained
from the Jackson Laboratories (Bar Harbour, ME) and bred under speciﬁc
pathogen-free conditions. Tnfr1/2 double-deﬁcient mice (Tnfr1,2 / ) were
generated by cross-breeding Tnfr1 / and Tnfr2 / mice. Ripk3 / mice
were kindly provided by V. Dixit, Genentech, USA and Mlkl / mice were
kindly provided by J. Murphy, WEHI, Australia. Mice were housed in groups of
ﬁve under speciﬁc pathogen-free conditions with unlimited access to food and
water. Six- to eight-week-old male mice received a single intraperitoneal (i.p.)
injection of 100mg kg 1 of sodium oxalate (Santa Cruz Biotechnology, USA) and
3% sodium oxalate in drinking water and kidneys were harvested after 24 h. As a
therapeutic strategy, mice received a single dose of either etanercept (10mg kg 1
i.p., Pﬁzer, Germany) or necrostatin-1 (1.65mg kg 1 i.p., Millipore, Germany) or
R-7050 (18mg kg 1 i.p., Santa Cruz Biotechnology, USA) before sodium oxalate
injections. Blood, urine and kidneys were collected at sacriﬁce by cervical dis-
location. Kidneys were kept at  80 C for protein isolation and in RNA later
solution at  20 C for RNA isolation. One part of the kidney was also kept in
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formalin to be embedded in parafﬁn for histological analysis. Samples for electron
microscopy were ﬁxed in glutaraldehyde. Sample sizes were determined by
G*Power (Germany). All kidney disease experimental procedures were approved
by the Regierung von Oberbayern, Mu¨nchen, Germany.
For peritonitis studies, peritonitis was induced by injection of 1mg of crystals in
0.5ml sterile PBS. Mice received a single injection of either Nec-1 (1.65mg kg 1)
or vehicle half an hour before crystals injections. After 6 h, mice were killed and
peritoneal cavities were washed with 5ml of PBS. The lavage ﬂuids were analysed
for polymorphonuclear neutrophil recruitment by ﬂuorescence-activated cell
sorting using the neutrophil marker Ly-6G (BD Biosciences, Germany).
For air pouch studies, murine air pouches were generated using standard
protocols in groups of 6-weeks-old Balb/c mice (n¼ 5). In brief, we injected 3ml of
sterile air subcutaneously into the back of anaesthetized mice to form an air pouch.
An additional 2ml of sterile air was injected into pre-existent pouch 3 days after
the ﬁrst injection7. Another 2 days later, we injected 2.5mg crystals in PBS, 2.5mg
crystals plus 1.65mg kg 1 necrostatin-1 into the air pouches. Crystals of CaOx,
MSU, CPPD and cystine were used in each independent experiment. After 24 h the
pouch ﬂuid was collected, and neutrophils in the air lavage were analysed by
ﬂuorescence-activated cell sorting. The studies were conducted according to
guidelines determined by the Law of the Ministry of Healthcare of Ukraine, No.
281 from 1 November 2011 for the care and use of laboratory animals and were
approved by the Ethics Council of the Danylo Halytsky Lviv National Medical
University.
For mouse cremaster muscle IR injury assay, cremaster muscle was prepared for
experiment as originally described by Baez with minor modiﬁcations36,37. Brieﬂy,
mice were anesthetized using intraperitoneal (i.p.) injection of ketamine/xylazine
mixture. The left femoral artery was cannulated for administration of microspheres
and drugs. The right cremaster muscle was exposed through a ventral incision of
the scrotum. Epididymis and testicle were detached from the cremaster muscle and
placed into the abdominal cavity. Throughout experimental procedure the muscle
was superfused with warm-buffered saline. Olympus BX 50 upright microscope
(Olympus Microscopy, Germany) equipped for stroboscopic ﬂuorescence epi-
illumination microscopy was used for in vivo microsopy. For measurement of
centerline blood ﬂow velocity, green ﬂuorescent microspheres (0.96 mm diameter,
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FMK (10mM) and Nec-1 (100mM) or NSA (1mM) before being exposed to CaOx (1000mgml 1), MSU (500mgml 1), CPPD (500mgml 1) and cystine
(500mgml 1). Cell viability was assessed by MTTassay (a and b) and cell death was assessed quantifying PI positivity (c) 24h later. Data are expressed as
mean±s.e.m. of three independent experiments. Baseline viability is set as 100%. Data were analysed using Student’s t-test. *Po0.05, **Po0.01,
***Po0.001 either versus vehicle control. (d) Primary renal human progenitor cells were stimulated with different crystals as indicated above for 18h. The
expression of Phospho-mlkl and total mlkl was detected by western blot with b-actin as a loading control. (e) Selective cases of human oxalate crystal-related
acute kidney injury were stained with PAS and for TNF-a, TNFR1 and phosphorylated MLKL. Representative images are shown at an original magniﬁcation of
1:400. Scale bar, 40mm. MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; PAS, periodic acid-Schiff; PI, prodidium iodide.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms10274 ARTICLE
NATURE COMMUNICATIONS | 7:10274 | DOI: 10.1038/ncomms10274 | www.nature.com/naturecommunications 11
Molecular Probes, Leiden, the Netherlands) were injected via the femoral artery
catheter, and their passage through the vessels of interest was recorded using the
ﬂuorescein isothiocyanate (FITC) ﬁlter cube under appropriate stroboscopic
illumination (exposure, 1ms; cycle time, 10ms; l¼ 488 nm), integrating video
images for sufﬁcient time (480ms) to allow for the recording of several images of
the same bead on one frame. Beads that were ﬂowing freely along the centerline of
the vessels were used to determine blood ﬂow velocity. For ofﬂine analysis of
parameters describing the sequential steps of leucocyte extravasation, we used the
Cap-Image image analysis software (Dr Zeintl, Germany). Animals were treated
with necrostatin-1 (1.65mg kg 1 i.p.) or vehicle 30min before the experiment. For
the analysis of postischemic leucocyte responses, three postcapillary vessel
segments in a central area of the spread out cremaster muscle were randomly
chosen. Ischaemia was induced by clamping all supplying vessels at the base of the
cremaster muscle using a vascular clamp (Martin, Germany). After 30min of
ischaemia, the vascular clamp was removed and reperfusion was restored for
160min. Measurements were repeated at 60 and 120min after onset of reperfusion.
Subsequently, FITC dextran was infused intra-arterial for the analysis of
microvascular permeability. Analysis of microvascular permeability was performed
as follows38. The macromolecule FITC dextran (5mg in 0.1ml saline, Mr
150,000Da, Sigma Aldrich) was infused intra-arterial after determination of
centerline blood ﬂow velocity. Mean grey values of ﬂuorescence intensity were
measured by digital image analysis (TILLvisION 4.0, TILL Photonics) in six
randomly selected regions of interest (50 50mm2), localized 50mm distant from
the postcapillary venule under investigation. The average of mean grey values was
calculated.
Assessment of renal injury. Mice kidney sections of 2 mm were stained with
periodic acid-Schiff reagent. Tubular injury was scored by assessing the percentage
of necrotic tubules and presence of tubular casts. Ly6B.2þ neutrophils were
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identiﬁed by immunostaining (1:200; Serotec, UK, #MCA771GA). Pizzolato’s
staining visualized CaOx crystals and crystal deposit formation in the kidney was
evaluated as in refs 5,39: no deposits¼ 0 point; crystals in papillary tip¼ 1 point;
crystals in cortical medullary junction¼ 2 points; crystals in cortex¼ 3 points.
When crystals were observed in multiple areas, the points were combined. The
expression of TNF-a (1:200, R&D, Germany, #AF410NA) and TNFR1 (1:800,
Abcam, UK, #ab19139) was analysed by immunostaining. Plasma creatinine and
BUN were measured using Urea FS kit (DiaSys Diagnostic Systems, Germany)
according to the manufacturer’s protocol. Neutrophil inﬁltrates were counted in 15
high power ﬁelds per section. A cell death detection (TUNEL) kit (Roche,
Germany) was used to quantify dead cells. A retrospective screening for CaOx
deposits in 64,000 medical and transplant kidney biopsies renal biopsies in the
Nephropath data base was performed (IRB number: 05-4397-0). An informed
consent was obtained from all subjects. Parafﬁn sections from human native kidney
biopsies were stained with 1:100 rabbit anti p-MLKL (Abcam, USA) and
anti-rabbit IgG Alexa Flur 555. All assessments were performed in a blind manner.
Electron microscopy. For scanning electron microscopy, kidney tissue were rinsed
with PBS and postﬁxed with 1% aqueous osmium tetroxide for a total of 2.5 h.
Subsequently, tissues were rinsed and dehydrated through a graded series of
ethanol to absolute ethanol and critical point dried using liquid CO2. After
mounting on stubs the specimens were sputter coated with a gold-palladium alloy
for 1.5min. Images were viewed with a Hitachi 2600 electron microscope.
For transmission electron microscopy, kidneys were immersed in cold modiﬁed
Karnovsky’s ﬁxative containing 3% glutaraldehyde and 1% paraformaldehyde in
sodium cacodylate buffer (pH 7.4) processed as follows5. After overnight ﬁxation,
kidneys were postﬁxed in 2% osmium tetraoxide, dehydrated through graded
concentrations of ethanol and embedded in EMBed-812. Ultrathin sections of
kidney were cut onto formvar-coated slot grids, and subsequently stained with
uranyl acetate and lead citrate. The samples were viewed with a JEOL model
1200EX electron microscope (JEOL, Tokyo, Japan).
In another experiment, mouse tubular cells (MTCs) were grown on Thincerts
(Greiner bio-one, Germany), and stimulated with crystals of CaOx
(1,000 mgml 1), MSU (500 mgml 1), CPPD (500 mgml 1) and cysteine
(500 mgml 1) for 24 h. Cells were then ﬁxed for 1 h at room temperature by
replacing the growth medium with 3% glutaraldehyde in PBS (pH 7.2). The
Thincerts were then washed three times with PBS (pH 7.2) buffer and sliced into
3-mm squares. These pieces were postﬁxed in 2% aqueous osmium tetroxide for 2 h
and then dehydrated through an ethanol series. After three washes in 100%
ethanol, the pieces were transferred to acetone, then inﬁltrated and embedded in
Epon. SectionsB70 nm thick were cut using a diamond knife, collected on copper
grids, and stained sequentially with uranyl acetate (saturated in 50% ethanol) and
Reynolds’ lead citrate. Sections were examined and photographed by a JEOL 1200
EXII transmission electron microscope at 80 kv.
For quick-freeze deep-etch electron microscopy, 1.5mm bread slices of
non-ﬁxed kidney or kidney sections ﬁxed overnight in 2% glutaraldehyde in
100mM NaCl, 30mM Hepes, 2mM CaCl2, pH 7.2 (NaHCa) were used after
rinsing in NaHCa. Tissues were then cooled to 4 K with liquid helium mounted in
a Balzers 400 vacuum evaporator fractured and etched for 2.5min at  104 C and
rotary replicated withB3 nm platinum. The process involved fracturing the kidney
sample with a cryomicrotome under high vacuum, then allowed to partially freeze
dry (this is called deep-etching), then covered with a thin ﬁlm of platinum that
forms a replica of the fractured and etched tissue. Then the sample was allowed to
thaw so that the replica could be collected40 and viewed with transmission
microscope (JEOL 1400 with attached AMT digital camera).
RNA preparation and real-time quantitative PCR. Total RNA was isolated from
kidneys using a Qiagen RNA extraction kit (Qiagen, Germany) following the
manufacturer’s instructions. After quantiﬁcation RNA quality was assessed using
agarose gels. From isolated RNA, complementary DNA was prepared using reverse
transcriptase (Superscript II; Invitrogen, USA). Real-time reverse transcription
PCR was performed using SYBRGreen PCR master mix and was analysed with a
Light Cycler 480 (Roche, Germany). All gene expression values were normalized
using 18 s RNA as a house keeping gene. All primers used for ampliﬁcation were
from Metabion (Martinsried, Germany). The expression of KIM-1, p-GST,
TNFR1, RIPK1, RIPK3 and MLKL was tested using primers as follows: Kim-1:
50-TCAGCTCGGGAATGCACA-30 (for), 50-TGGTTGCCTTCCGTGTCT-30 (rev);
p-GST: 50-CGCAGCACTGAATCCGCACC-30 (for), 50-ACACCGCCCTCGA
ACTGGGAA-30 (rev); TNFR1:-50-GCAACAGCACCGCAGTAGCTGA-30 (for),
50-GTGCGTCCCTTGCAGCCACT-30 (rev); RIPK1: 50-GACTGTGTACCCTTA
CCTCCGA-30 (for), CACTGCGATCATTCTCGTCCTG50- (rev); RIPK3:
50-GAAGACACGGCACTCCTTGGTA-30 (for), 50-CTTGAGGCAGTAGTT
CTTGGTGG-30 (rev), MLKL: 50-CTGAGGGAACTGCTGGATAGAG-30 (for),
50-CGAGGAAACTGGAGCTGCTGAT-30 (rev), Caspase-8: 50-ATGGCTACGG
TGAAGAACTGCG-30 (for), 50-TAGTTCACGCCAGTCAGGATGC-30 (rev).
Cell culture studies. MTCs, human synovial ﬁbroblasts (K4IM cells) and L929
cells were maintained in DMEM/F12 (GIBCO, Invitrogen, CA, USA) containing
10% fetal calf serum, 1% penicillin–streptomycin. Human kidney cells (HK-2) were
maintained in RPMI (GIBCO, Invitrogen, CA, USA) containing 10% fetal calf
serum and 1% penicillin–streptomycin. MTCs are a cell line immortalized with
SV-40 virus41, and K4IM cells are a cell line immortalized with SV-40 T large
antigen42,43. MTCs and K4IM cells were generously provided by EG Neilson and
PJ Nelson, respectively. L929 and HK-2 cells were originally purchased from
ATCC, and were generously provided by B Luckow and PJ Nelson, respectively.
Human renal progenitor cells were prepared from human kidney tissues using
standard sieving technique through graded mesh screens (60, 80, 150 and 200
mesh)24. All cells were stimulated with different doses of crystals of CaOx (1–2 mm
size; Alfa aesar, Germany), MSU (25–125 nm size; Invivogen, Germany), CPPD
(25–125 nm size; Invivogen, Germany) and cystine (1–2 mm size; Sigma Aldrich,
Germany) in different experiments. Cells were pretreated with necrostatin-1 (50 or
100 mM) or ZVAD-FMK (10 mM) or combination or RIPK3 inhibitor dabrafenib
(Selleckchem, Germany) 30min before crystals stimulations whenever required.
Primary tubular epithelial cells were isolated from the kidneys and were
maintained in DMEM/F12 containing 10% fetal calf serum, 1% penicillin–
streptomycin, 125 ngml 1 prostaglandin E1 (Calbiochem, Germany), 25 ngml 1
EGF, 1.8 mgml 1 l-thyroxine, 3.38 ngml 1 hydrocortisone and 2.5mgml 1 of
insulin–transferrin—sodium selenite supplement (all from Sigma Aldrich,
Germany unless mentioned). Cells were grown to conﬂuence before use in
experiments. Primary renal human progenitor cells were plated in EGM-MV
(Lonza Ltd., Basel, Switzerland) with 20% FBS (Hyclone, Logan, Utah). Generation
of clones was achieved by limiting dilution in 96-well plates and in four-chamber
glass slides (VWR International, West Chester, Pennsylvania). All the cells were
cultured in an incubator at 37 C, 5%CO2. CellTiter 96 non-radioactive cell
proliferation assay (MTT) kit (Promega, Germany) was used to evaluate cell
survival after 24 h following the manufacturer’s instructions. Results were
expressed as percentage of the vehicle control.
Small interfering RNA experiments. MTCs were transiently transfected with
25 nM of SiRNA duplexes speciﬁc for RIPK3 (s80755), MLKL (s92952), Caspase-8
(s63394), and scrambled siRNA (negative control no.1) (Ambion, USA) using
Lipofectamine RNAiMAX transfection reagent (Life Technologies, Germany). 24 h
after transfection cells were challenged to CaOx (1,000 mgml 1), MSU
(500 mgml 1), CPPD (500 mgml 1) and cystine (500 mgml 1) for 24 h. Cell
death was measured by prodidium iodide positivity and cell viability was analysed
using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay.
Following small RNA sequences were used. Ripk3: 50-CGGCUCUCGUCUUC
AACAAtt-30 (sense), 50-UUGUUGAAGACGAGAGCCGgt-30 (antisense);
Mlkl: 50-GAACCUGCCCGAUGACAUUtt-30 (sense), 50-AAUGUCAUCGGG
CAGGUUCtt-30 (antisense); Casp8: 50-CAAGAACUAUAUUCCGGAUtt30
(sense), 50-AUCCGGAAUAUAGUUCUUGtg-30 (antisense).
Protein isolations and immunoblots. Protein from kidney tissues and cells
were extracted using lysis buffer (Tris-HCl 50mM, NaCl 150mM, sodium
orthovanadate 100 mM, sodium deoxycholate 0.5%, NP40 4%, Triton X-100 2%,
EDTA 5mM, sucrose 300mM, and Roche protease inhibitors). Total cellular
extracts were prepared in protein lysis buffer (Tris 10mM, NaCl 10mM,
ethylenediaminetetraacetic acid 10mM, HEPES 1mol l 1, glycerol 20%, MgCl2
1mol l 1, dithiothreitol 1mol l 1, Triton 10% sodium ﬂuoride 1mol l 1 and
Roche protease inhibitors). After determination of protein concentrations, 50 mg of
the kidney protein or 10mg of protein extracted from cells was mixed with
5 sodium dodecyl sulfate loading buffer (100mmol l 1 Tris-HCl, 4% sodium
dodecyl sulfate, 20% glycerol and 0.2% bromophenol blue) for western blot ana-
lysis. Samples were heated at 95 C for 5min. Proteins were separated by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis and then transferred to a
polyvinylidene diﬂuoride membrane. Nonspeciﬁc binding to the membrane
was blocked for 1 h at room temperature with 5% bovine serum albumin in
tris-buffered saline buffer (20mmol l 1 Tris-HCl, 150mmol l 1 NaCl and 0.1%
Tween 20). The membranes were then incubated overnight at 4 C with the
following primary antibodies: TNFR1 (1:500, Abcam, UK, #ab19139), RIPK1
(1:200, BD, Germany, #610459), RIPK3 (1:200, Abcam, UK, #ab152130), anti-
human phospho-MLKL (1:200, Millipore, Germany, #ABC234), anti-human total
MLKL (1:200, Millipore, Germany, #17-10400), total MLKL (1:500, Abcam, UK,
#ab194699) and b-actin (1:1000, Cell Signalling, USA, #4967), followed by incu-
bation with secondary antibody anti-biotin or anti-rabbit IgG labelled with HRP.
Immunostained bands were detected using a chemiluminescence kit (ECL kit, GE
Healthcare, UK). Immunoblot images in Figs 2 and 9 as well as Supplementary
Figs 3 and 5 have been cropped for presentation. Full size images are presented in
Supplementary Figs 9 and 10.
Multi-parameter classiﬁcation of cell death by ﬂow cytometry. Cell death was
induced in MTCs by irradiation with ultraviolet light type B at 1.5mJ cm 2 s 1 or
by treatment with CaOx crystals. Cell death was characterized by analysing six
cytoﬂuorometric parameters (size, granularity, penicillin–streptomycin exposure,
plasma membrane integrity, mitochondrial membrane potential and DNA content)
in a single tube measurement. This method detects eight phenotypically different
subpopulations during the development of cell death in vitro. Brieﬂy, collected cells
were incubated for 30min at room temperature with 400 ml of freshly prepared
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four-colour staining solution (1.8 mgml 1 AxA5-FITC, 100 ngml 1 prodidium
iodide and 10 nM DiIC1(5), 1 ngml 1 Hoechst 33342) in Ringer’s solution
and subsequently analysed. Flow cytometry was performed with a Gallios
cytoﬂuorometer (Beckman Coulter, Fullerton, USA). Excitation of FITC and
prodidium iodide was at 488 nm, the FITC ﬂuorescence was detected with the FL1
sensor (525/38 nm band pass (BP) ﬁlter), the prodidium iodide ﬂuorescence with
the FL3 sensor (620/30 nm BP), the DiIC1(5) ﬂuorescence was excited at 638 nm
and detected with the FL6 sensor (675/20 nm BP), and the Hoechst 33342 ﬂuor-
escence was excited at 405 nm and detected with the FL9 sensor (430/40 nm BP).
Electronic compensation was applied to reduce bleed through ﬂuorescence. Data
analysis was performed with Kaluza software version 2.0 (Beckman Coulter,
Fullerton, USA). Cells were classiﬁed according to their location in the forward
scatter (FSc; size) versus side scatter (SSc; granularity) dot plot and their staining
patterns in the FL1 versus FL3 and FL6 versus FL9 dot plots as described else-
where44. In brief, cells were considered viable, if they (V1) do not expose
phosphatidylserine on their surfaces (V2) display high mitochondrial membrane
potential and (V3), if they exclude propidium iodide. Apoptotic cells are deﬁned by
(A1) exposure on their surfaces of phosphatidylserine (A2) and exclusion of
propidium iodide. Cells are considered necrotic, if they display (N) permeability for
the propidium cation of their plasma membranes. Cells are considered necrotic, if
they allow the penetration of propidium iodide. Primary necrotic cells (no signs of
apoptosis) do not display nuclear hypochromicity for propidium iodide (nuclear
DNA is preserved). If the nuclei show nuclear hypochromicity (apoptosis has
already started) the cells were considered secondary necrotic (loss of membrane
selectivity of a cell executing apoptosis).
Statistical analysis. Data are presented as mean±s.e.m. A comparison of groups
was performed using paired Students t-test or one-way analysis of variance with
post hoc Bonferroni’s correction was used for multiple comparisons. A value of
Po0.05 was considered to indicate statistical signiﬁcance.
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